Real-world evidence on the use of hospital resources for subcutaneous and intravenous trastuzumab administration in breast cancer patients at a referral public hospital in Mexico
In a routine public oncology setting with limited resources, the use of SC trastuzumab was associated with clear advantages in terms of efficiency and the treatment experience while also mitigating the workload of infusion areas. These results provide practical, context-specific evidence that could help healthcare systems to improve the organization of oncology services and make better use of scarce hospital resources.
Authors
- Tatiana Fiordelisio (ORCID: https://orcid.org/0000-0002-9282-1476)
- Francisco Valdés-Souto (ORCID: https://orcid.org/0000-0001-6736-0666)
- Diego Zamarrón-Hernández (ORCID: https://orcid.org/0000-0002-8315-5504)
- Diana Del-Rio (ORCID: https://orcid.org/0000-0002-7587-0866)
- Karla Ramírez Pulido
- Claudia Haydee Arce Salinas
- Cristopher Alejandro Escamilla Soto (ORCID: https://orcid.org/0009-0006-9688-0576)
- Yair Uriel Correa Trejo (ORCID: https://orcid.org/0009-0008-9611-9888)
- Isabel Espino Gutiérrez
- Claudia Itzel Gutiérrez Sánchez
Institutions
- Instituto Nacional de Cancerología (MX)
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Journal of Comparative Effectiveness Research
- Published
- 2026-04-20
- DOI
- https://doi.org/10.57264/cer-2025-0199
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00